Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer (Guardant Health)

Guardant Health’s COSMOS study, published in Clinical Cancer Research, validates the effectiveness of the Guardant Reveal liquid biopsy test in predicting the recurrence of colorectal cancer. The study demonstrated that this non-invasive test could identify patients at higher risk of recurrence, potentially leading to more tailored and timely treatment interventions. The findings highlight the growing utility of liquid biopsy in the ongoing management of cancer patients, offering a significant advance in personalized cancer care.